Plavsic Mark
Chief Technology Officer
Plavsic Mark has filed 3 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Mar 3, 2026.
On the most recent filing, Plavsic Mark is listed as Chief Technology Officer at Aura Biosciences, Inc. Inside the rolling window, Plavsic Mark reported no open-market purchases and 2 open-market sales totaling $158K in AURA. The largest disclosed transaction in the window is a sale of 15,890 AURA shares on Feb 17, 2026, worth $80K.
Companies traded
Other insiders at AURA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$158K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Plavsic Mark made?
Plavsic Mark has filed 3 SEC Form 4 filings (3 transaction rows) across 1 company since 2025.
Which companies does Plavsic Mark trade?
Plavsic Mark has filed SEC Form 4 disclosures for 1 company, including AURA.
When was Plavsic Mark's most recent SEC Form 4 filing?
Plavsic Mark's most recent SEC Form 4 filing on Tracefour is dated Mar 3, 2026.
What is Plavsic Mark's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Plavsic Mark is listed as Chief Technology Officer.
What is Plavsic Mark's total buy and sell value in the current window?
Inside the rolling retention window, Plavsic Mark bought $0 and sold $158K based on SEC Form 4 filings.
What was Plavsic Mark's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 15,890 AURA shares on 2026-02-17, worth $80K, per SEC Form 4 filings.